The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The National Cancer Data Base report on the utilization of an adjuvant immunotherapy in stage III melanoma in relation to age.
Arden Fredeking
No relevant relationships to disclose
Suraj S. Venna
No relevant relationships to disclose
Sekwon Jang
No relevant relationships to disclose